Citation 143582

WAGNER,MM: PAUL,DC: SHIH,C: JORDAN,MA: WILSON,L: WILLIAMS,DC:. (1999). IN VITRO PHARMACOLOGY OF CRYPTOPHYCIN 52 (LY355703) IN HUMAN TUMOR CELL LINES.. 43(2)

Citation Details

Title	IN VITRO PHARMACOLOGY OF CRYPTOPHYCIN 52 (LY355703) IN HUMAN TUMOR CELL LINES.
Authors	WAGNER,MM: PAUL,DC: SHIH,C: JORDAN,MA: WILSON,L: WILLIAMS,DC:
Year	1999
Volume	43
Issue	2

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
2	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
3	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
4	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
5	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
6	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
7	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
8	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
9	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
10	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
11	CELL CYCLE CYTOTOXICITY(G2 + M PHASE)	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
12	ANTIMITOTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	WEAK ACTIVITY
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPHYCIN 52	ACTIVE

Show SPARQL Queries (1)